APT: APT announces patient dosing in PHAGE clinical trial evaluating bacteriophage therapy

Adaptive Phage Therapeutics, Inc., (APT) a clinical─stage biotechnology company advancing the APT phage bank, the world's largest therapeutic phage initiative for treatment of bacterial infectious diseases, announced